Whitepaper: Patient-Focused Solutions for Higher Value Care in the Specialty Drug Market
This whitepaper illustrates how a commitment to connecting patients to their therapies and a sensitivity to the patient journey can make the difference between success and failure.
Nearly 75% of adults are nonadherent to prescription medications. The cost is estimated at $100-300 billion annually.
But do affordable and accessible patient-focused solutions exist?
This whitepaper illustrates how a commitment to connecting patients to their therapies and a sensitivity to the patient journey can make the difference between success and failure.
Breaking Down Health Plans, HSAs, AI With Paul Fronstin of EBRI
November 19th 2024Featured in this latest episode of Tuning In to the C-Suite podcast is Paul Fronstin, director of health benefits research at EBRI, who shed light on the evolving landscape of health benefits with editors of Managed Healthcare Executive.
Listen
In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting Loren McCaghy, director of consulting, health and consumer engagement and product insight at Accenture, to discuss the organization's latest report on U.S. consumers switching healthcare providers and insurance payers.
Listen
